激酶域中的突变改变了VEGFR2膜动力学
Michela Corsini1,2, Cosetta Ravelli1,3, Elisabetta Grillo1,3
1Department of Molecular and Translational Medicine, University of Brescia, 25123 Brescia, Italy.
Cells
|August 28, 2024
概括
与癌症相关的VEGFR2R1051Q突变通过形成异构体来改变野生型VEGFR2 (VEGFR2WT) 的膜动力学. 这种相互作用减少了VEGFR2WT.
科学领域:
- 分子生物学分子生物学
- 细胞生物学 细胞生物学
- 生物物理学的生物物理.
背景情况:
- VEGFR2R1051Q突变是一种与癌症相关的功能增益突变.
- VEGFR2R1051Q表现出连体独立的酸化,增强细胞生长.
- 癌症中的异性表明VEGFR2R1051Q与野生型VEGFR2 (VEGFR2WT) 相互作用.
研究的目的:
- 研究VEGFR2R1051Q激活的生物物理机制.
- 确定VEGFR2R1051Q如何影响共同表达的VEGFR2WT的二分化和膜动态.
主要方法:
- 使用定量光终身成像显微镜 (FLIM) /福斯特共振能量转移 (FRET) 和光漂白后光恢复 (FRAP).
- 采用了与VEGFR2R1051Q和VEGFR2WT共传染的中国仓鼠卵巢 (CHO) 细胞来模仿异构性.
主要成果:
- 膜蛋白生物化表明VEGFR2WT比VEGFR2R1051Q更容易暴露.
- 图像分析证实VEGFR2WT与VEGFR2R1051Q形成异构体.
- 同表达导致侧向运动率降低,VEGFR2WT的移动分数较小.
结论:
- 活跃的VEGFR2R1051Q会影响VEGFR2WT的膜行为.
- 在VEGFR2R1051Q和VEGFR2WT之间的异构化改变了VEGFR2WT的膜动态.
相关概念视频
Receptor Tyrosine Kinases
12.5K
Receptor tyrosine kinases or RTKs are membrane-bound receptors that phosphorylate specific tyrosine on protein substrates. RTKs regulate cellular growth, differentiation, survival, and migration. They contain an extracellular ligand binding domain, a transmembrane domain, and a cytosolic tail with intrinsic kinase activity. Several extracellular signaling molecules activate RTKs in one or more ways and relay the signal downstream. Ligands such as platelet-derived growth factor (PDGF) or...
12.5K
PI3K/mTOR/AKT Signaling Pathway
3.4K
The mammalian target of rapamycin (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast, mTORC2 consists of a...
3.4K
MAPK Signaling Cascades
5.3K
Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
5.3K
mTOR Signaling and Cancer Progression
3.8K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.8K
Amplifying Signals via Enzymatic Cascade
8.4K
When a ligand binds to a cell-surface receptor, the receptor's intracellular domain changes shape, which may either activate its enzyme function or allow its binding to other molecules. The initial signal is amplified by most signal transduction pathways. This means that a single ligand molecule can activate multiple molecules of a downstream target. Proteins that relay a signal are most commonly phosphorylated at one or more sites, activating or inactivating the protein. Kinases catalyze...
8.4K
Regulation of Angiogenesis and Blood Supply
2.5K
Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits. Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl...
2.5K


